Special Investigation Of Long Term Use Of Sertraline.
Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
Special investigation of long term use of sertraline, 52 Week Observation, Long-Term Safety.
The objective of this "Special investigation" is to collect information about 1) adverse drug
reactions not expected from the LPD (unknown adverse drug reactions), 2) the incidence of
adverse drug reactions in this surveillance, and 3) factors considered to affect the safety
and/or efficacy of this drug regarding long time use.
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.